Arrhythmia Archives - Clinical Advisor

Arrhythmia

Ischemic event warning added to Multaq label

The FDA has issued a warning that the heart drug dronedarone (Multaq) should not be prescribed to patients with permanent atrial fibrillation because of an increased risk of serious cardiovascular events, including death.

Next post in Features